News Sartorius Stedim Biotech

Equities

DIM

FR0013154002

Market Closed - Euronext Paris Other stock markets 11:35:15 2024-05-31 am EDT			5-day change	1st Jan Change
182.6 ^EUR	-0.27%		-5.14%	-23.74%

May. 16	Sartorius sinks again towards year low	DP
May. 16	Transcript : Sartorius Stedim Biotech S.A., Sartorius Aktiengesellschaft - Analyst/Investor Day

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast	May. 17	EQ
Sartorius sinks again towards year low	May. 16	DP
Transcript : Sartorius Stedim Biotech S.A., Sartorius Aktiengesellschaft - Analyst/Investor Day	May. 16
Certain Shares of Sartorius Stedim Biotech S.A. are subject to a Lock-Up Agreement Ending on 8-MAY-2024.	May. 07	CI
SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating	Apr. 23	ZD
Sartorius Stedim: in the red with brokerage comments	Apr. 22	CF
UBS Cuts Sartorius Stedim Biotech PT, Maintains at Neutral	Apr. 22	MT
SARTORIUS STEDIM BIOTECH : Q1 24: A few positives despite the top-line miss	Apr. 22
SARTORIUS STEDIM : UBS reduces target price	Apr. 22	CF
Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix...	Apr. 18
Transcript : Sartorius Stedim Biotech S.A., Q1 2024 Earnings Call, Apr 18, 2024	Apr. 18
Transcript : Sartorius Aktiengesellschaft, Sartorius Stedim Biotech S.A., Q1 2024 Earnings Call, Apr 18, 2024	Apr. 18
Sartorius and subsidiary Stedim under pressure after weak figures	Apr. 18	DP
Sartorius Stedim: Quarterly EPS more than halved	Apr. 18	CF
Sartorius Stedim Biotech S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Sartorius Stedim Biotech Records Lower Q1 Attributable Net Profit, Sales Revenue	Apr. 18	MT
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024	Apr. 18	EQ
Ex-dividend day for final dividend	Apr. 01	FA
Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.	Mar. 26	EQ
Transcript : Sartorius Stedim Biotech S.A. - Shareholder/Analyst Call	Mar. 26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SARTORIUS STEDIM BIOTECH : Q1 24: A few positives despite the top-line miss

April 22, 2024 at 07:56 am EDT